Published in Psychooncology on March 01, 2011
Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life | NCT03585218
Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors. Psychooncology (2012) 0.92
Psychosocial issues in post-treatment cancer survivors: Desire for support and challenges in identifying individuals in need. J Psychosoc Oncol (2016) 0.78
Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res (2014) 0.78
Development of salutogenetic factors in mental health - Antonovsky's sense of coherence and Bandura's self-efficacy related to Derogatis' symptom check list (SCL-90-R). Health Qual Life Outcomes (2013) 0.76
Intrinsic religiousness and well-being among cancer patients: the mediating role of control-related religious coping and self-efficacy for coping with cancer. J Behav Med (2014) 0.76
Indicators of distress in newly diagnosed breast cancer patients. PeerJ (2015) 0.75
Protocol for a cluster randomised trial of a communication skills intervention for physicians to facilitate survivorship transition in patients with lymphoma. BMJ Open (2016) 0.75
Issues in Developing and Evaluating a Culturally Tailored Internet Cancer Support Group. Comput Inform Nurs (2016) 0.75
Psychosocial concerns and needs of cancer survivors treated at a comprehensive cancer center and a community safety net hospital. Support Care Cancer (2016) 0.75
Predicting Post Traumatic Growth Based upon Self-Efficacy and Perceived Social Support in Cancer Patients. Iran J Cancer Prev (2014) 0.75
The development of a complex intervention in China: the 'Caring for Couples Coping with Cancer "4Cs" Programme' to support couples coping with cancer. BMC Palliat Care (2015) 0.75
A cluster randomized trial of a primary palliative care intervention (CONNECT)for patients with advanced cancer: Protocol and key design considerations. Contemp Clin Trials (2017) 0.75
The closer 'We' are, the stronger 'I' am: the impact of couple identity on cancer coping self-efficacy. J Behav Med (2016) 0.75
"Letting Go": From Ancient to Modern Perspectives on Relinquishing Personal Control-A Theoretical Perspective on Religion and Coping with Cancer. J Relig Health (2017) 0.75
Colorectal cancer patient's self-efficacy for managing illness-related problems in the first 2 years after diagnosis, results from the ColoREctal Well-being (CREW) study. J Cancer Surviv (2017) 0.75
First Descents, an adventure program for young adults with cancer: who benefits? Support Care Cancer (2017) 0.75
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36
Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03
An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med (2011) 2.39
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
Transformation of acute cancer pain to chronic cancer pain syndromes. J Support Oncol (2012) 2.08
Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01
Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81
Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol (2011) 1.79
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer (2006) 1.67
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain (2006) 1.61
Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother (2006) 1.56
Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55
Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med (2012) 1.53
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage (2002) 1.50
Weighing in on the off-label use of Actiq for noncancer-related pain: a recipe for success or a recipe for disaster? Pain Med (2007) 1.49
Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain (2007) 1.48
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43
A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther (2004) 1.40
Fatigue associated with cancer and its treatment. Support Care Cancer (2001) 1.38
Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32
Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev (2012) 1.29
Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28
Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer (2004) 1.28
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Management of cancer-related fatigue. Cancer Invest (2005) 1.26
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer (2005) 1.18
A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage (2002) 1.17
Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med (2009) 1.15
Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13
A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13
Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Canc Netw (2003) 1.12
Caring for Somali women: implications for clinician-patient communication. Patient Educ Couns (2007) 1.10
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest (2004) 1.10
The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med (2003) 1.09
Patient-reported outcome measures suitable to assessment of patient navigation. Cancer (2011) 1.09
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07
Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage (2002) 1.06
Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain (2002) 1.05
Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials (2012) 1.03
Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project. J Pain Symptom Manage (2002) 1.02
IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest (2010) 1.02
A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med (2009) 1.01
Management of chronic noncancer pain in the primary care setting. South Med J (2007) 1.00
The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00
Brief report: pain and readiness to quit smoking cigarettes. Nicotine Tob Res (2006) 1.00
Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Support Care Cancer (2007) 0.98
Opioid therapy in patients with a history of substance abuse. CNS Drugs (2004) 0.98
Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study. J Clin Oncol (2003) 0.98
Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat (2004) 0.97
Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med (2008) 0.97
Clinician-patient communication about physical activity in an underserved population. J Am Board Fam Med (2008) 0.97
A feasibility study of dignity psychotherapy delivered via telemedicine. Palliat Support Care (2004) 0.97
The role of religious coping in adjustment to cancer. Psychooncology (2003) 0.96
Religious beliefs, social support, self-efficacy and adjustment to cancer. Psychooncology (2009) 0.96
Randomized controlled trial of patient navigation for newly diagnosed cancer patients: effects on quality of life. Cancer Epidemiol Biomarkers Prev (2012) 0.93
Empathy and the failure to treat pain. Palliat Support Care (2007) 0.93
Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer (2006) 0.93
Eliminating disparities in cancer screening and follow-up of abnormal results: what will it take? J Health Care Poor Underserved (2011) 0.93
Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer (2001) 0.92
Pharmacologic treatment of cancer-related fatigue. Oncologist (2007) 0.92
Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manag (2007) 0.92
The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol (2008) 0.92
Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors. Psychooncology (2012) 0.92
Pain clinicians' rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother (2002) 0.92
An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea. J Pain Symptom Manage (2010) 0.90
The role of patients' response expectancies in side effect development and control. Curr Probl Cancer (2006) 0.90
Substance abuse in cancer pain. Curr Pain Headache Rep (2010) 0.89
Assessing aberrant drug-taking behaviors in the patient with chronic pain. Curr Pain Headache Rep (2004) 0.89
How do patient expectancies, quality of life, and postchemotherapy nausea interrelate? Cancer (2008) 0.89
Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain. J Opioid Manag (2011) 0.89
Self-reported cognitive impairment in patients with cancer. J Oncol Pract (2007) 0.89
Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation. Palliat Support Care (2004) 0.88
Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care (2007) 0.88
A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. J Pain Symptom Manage (2003) 0.88
Managing pain in patients with aberrant drug-taking behaviors. J Support Oncol (2005) 0.87
Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psychooncology (2006) 0.87
Stability of decisional role preference over the course of cancer therapy. Psychooncology (2006) 0.86
My mind is as clear as it used to be: A pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer. J Pain Symptom Manage (2003) 0.86
An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. J Pain Symptom Manage (2003) 0.85
Acupressure bands are effective in reducing radiation therapy-related nausea. J Pain Symptom Manage (2009) 0.84
Palliative care of the terminally ill drug addict. Cancer Invest (2006) 0.84